Evidence map›Paper›PMID 25397673›Full record

Trial reportPloS one2014

Detection of pneumonia associated pathogens using a prototype multiplexed pneumonia test in hospitalized patients with severe pneumonia.

Berit Schulte, Holm Eickmeyer, Alexandra Heininger, Stephanie Juretzek, Matthias Karrasch, Olivier Denis, Sandrine Roisin, Mathias W Pletz, Matthias Klein, Sandra Barth and 7 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Droplet Digital PCR forAntibiotics (Basel, Switzerland) · 2024
    Article
  3. Review
  4. Article
  5. An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Observational
  11. Comparison of Unyvero P55 Pneumonia Cartridge, in-house PCR and culture for the identification of respiratory pathogens and antibiotic resistance in bronchoalveolar lavage fluids in the critical care setting.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Community-acquired pneumonia.Lancet (London, England) · 2015
    Review
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Berit SchulteInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany; German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Holm EickmeyerHeart and Diabetes Center North Rhine-Westphalia, Institute for Laboratory- and Transfusion Medicine, University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germany; Heart and Diabetes Center North Rhine-Westphalia, Clinic for Thoracic and Cardiovascular Surgery, University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germany.
Alexandra HeiningerGerman Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany; Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Tübingen, Germany.
Stephanie JuretzekUniversity Hospital Jena, Institute of Medical Microbiology, Jena, Germany.
Matthias KarraschUniversity Hospital Jena, Institute of Medical Microbiology, Jena, Germany.
Olivier DenisUniversité Libre de Bruxelles, Laboratory of Microbiology, Bruxelles, Belgium.
Sandrine RoisinUniversité Libre de Bruxelles, Laboratory of Microbiology, Bruxelles, Belgium.
Mathias W PletzUniversity Hospital Jena, Center for Infectious Diseases and Infection Control, and Center for Sepsis Care and Control, Jena, Germany.
Matthias KleinCuretis AG, Holzgerlingen, Germany.
Sandra BarthCuretis AG, Holzgerlingen, Germany.
Gerd H LüdkeCuretis AG, Holzgerlingen, Germany.
Anne ThewsCuretis AG, Holzgerlingen, Germany.
Antoni TorresDepartment of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain.
Catia CillónizDepartment of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain.
Eberhard StraubeUniversity Hospital Jena, Institute of Medical Microbiology, Jena, Germany; University Hospital Jena, Center for Infectious Diseases and Infection Control, and Center for Sepsis Care and Control, Jena, Germany.
Ingo B AutenriethInstitute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany; German Centre for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.
Peter M KellerUniversity Hospital Jena, Institute of Medical Microbiology, Jena, Germany; University Hospital Jena, Center for Infectious Diseases and Infection Control, and Center for Sepsis Care and Control, Jena, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledSevere pneumonia remains an important cause of morbidity and mortality. Polymerase chain reaction (PCR) has been shown to be more sensitive than current standard microbiological methods--particularly in patients with prior antibiotic treatment--and therefore, may improve the accuracy of microbiological diagnosis for hospitalized patients with pneumonia. Conventional detection techniques and multiplex PCR for 14 typical bacterial pneumonia-associated pathogens were performed on respiratory samples collected from adult hospitalized patients enrolled in a prospective multi-center study. Patients were enrolled from March until September 2012. A total of 739 fresh, native samples were eligible for analysis, of which 75 were sputa, 421 aspirates, and 234 bronchial lavages. 276 pathogens were detected by microbiology for which a valid PCR result was generated (positive or negative detection result by Curetis prototype system). Among these, 120 were identified by the prototype assay, 50 pathogens were not detected. Overall performance of the prototype for pathogen identification was 70.6% sensitivity (95% confidence interval (CI) lower bound: 63.3%, upper bound: 76.9%) and 95.2% specificity (95% CI lower bound: 94.6%, upper bound: 95.7%). Based on the study results, device cut-off settings were adjusted for future series production. The overall performance with the settings of the CE series production devices was 78.7% sensitivity (95% CI lower bound: 72.1%) and 96.6% specificity (95% CI lower bound: 96.1%). Time to result was 5.2 hours (median) for the prototype test and 43.5 h for standard-of-care. The Pneumonia Application provides a rapid and moderately sensitive assay for the detection of pneumonia-causing pathogens with minimal hands-on time.

trial registrationDeutsches Register Klinischer Studien (DRKS) DRKS00005684.

Indexed as

AdultAgedAged, 80 and overBacteriaFemaleHospitalizationHumansMaleMiddle AgedMultiplex Polymerase Chain ReactionPneumoniaYoung Adult

Identifiers

PMID25397673
PMCPMC4232251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.